In the present study, we found ALKBH5, one of m6A epitranscriptomics enzyme, was highly increased in HBV-HCC tissues with prognosis prediction value, and targeting ALKBH5 inhibits tumor cells’ growth and migration. Here, ALKBH5 is linked to neoplasm.